L. F. C. de Almeida, “CDK4/6 inhibitor plus endocrine therapy after progression on CDK4/6 inhibition in HR+/HER2- advanced breast cancer: a systematic review and meta-analysis (ReIGNITE study)”, MAST, vol. 35, no. suppl.1, Feb. 2026.